consulting fees from Boehringer Ingelheim, GSK and Otsuka and speaking fees from Amgen and Sanofi (Mexico), but has not received funding in relation to the writing of this article
Side effects are rare but may include nausea, mild headaches, or allergic reactions in some individuals
By considering all of these factors, Troy Watson provides a tailored approach to weight loss, ensuring you receive the most appropriate and effective treatment for your specific needs
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
Molecular Aspects of Medicine 28, 481-506
ng thi, sn phm cn gip ti to t bo da mi, lm cho da trng tr hn v sng hn